ProCE Banner Activity

Interferons: Here to Stay for HDV Treatment?

Clinical Thought

I think interferons will continue to have an important role in HDV treatment even after the approval of many of the novel therapies.

Released: March 28, 2023

Share

Faculty

Heiner Wedemeyer

Heiner Wedemeyer, MD

Professor and Chairman
Department of Gastroenterology, Hepatology and Endocrinology
Hannover Medical School
Hannover, Germany

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

Faculty Disclosure

Heiner Wedemeyer, MDconsultant/advisor/speaker: Falk, Gilead, GlaxoSmithKline, Janssen, Merck Sharp and Dohme, Roche, Vir Pharmaceuticals; researcher: Biotest.